Cell death and immune privilege

International Reviews of Immunology

Volumn 21, Issue 2-3, 2002, Pages 153-172

  Ferguson, Thomas A ^a   Green, Douglas R ^b   Griffith, Thomas S ^c  

^a WASHINGTON UNIVERSITY   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Apoptosis; Fas; FasL; Immune privilege; Immune tolerance; T lymphocytes

Indexed keywords

ANIMAL; CELL DEATH; EYE; GRAFT SURVIVAL; HUMAN; IMMUNE TOLERANCE; MEMBRANE GLYCOPROTEINS; SUPERANTIGENS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR; ANIMALS; FAS LIGAND PROTEIN; HUMANS; TUMOR NECROSIS FACTOR-ALPHA;

FAS LIGAND; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN; SUPERANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ALLOTRANSPLANTATION; ANIMAL; CELL DEATH; EYE; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PHYSIOLOGY; REVIEW;

EID: 0035997384     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.1080/08830180212058     Document Type: Review

References (64)

1. Transgenic expression of CD95 ligand on islet β cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts
2. Restricted expression of an adenoviral vector encoding Fas ligand (CD95L) enhances safety for cancer gene therapy
3. Extracellular matrix interacts with soluble CD95L: Retention and enhancement of cytotoxicity
4. Transgenic expression of Fas ligand on thyroid follicular cells prevents autoimmune thyroiditis
5. A role for CD95 ligand in preventing graft rejection
6. Inducible nonlymphoid Fas-ligand is responsible for superantigen-induced peripheral deletion of T-cells
7. Regulation of the proinflammatory effects of Fas ligand (CD95L)
8. TGF-β released by apoptotic T cells contributes to an immunosuppressive milieu
9. Requirement for transforming growth factor beta1 in controlling T cell apoptosis
10. Testicular FasL is expressed by sperm cells
11. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance
12. Neuropeptides modulate immune deviation induced via the anterior chamber of the eye
13. The immune response and the eye. IV. A role for tumor necrosis factor in anterior chamber associated immune deviation
14. The wavelength of light governing intraocular immune reactions
15. A vision of cell death: Insights into immune privilege
16. Anti-inflammatory effects of CD95 ligand (FasL)-induced apoptosis
17. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis
18. Airway epithelial Fas ligand expression: Potential role in modulating bronchial inflammation
19. Fas ligand induced apoptosis as a mechanism of immune privilege
20. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunologic tolerance
21. Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L)
22. A critical role for Fas ligand in the active suppression of systemic immune responses by ultraviolet light
23. Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival
24. Inhibition of lymphocyte proliferation by resident ocular cells
25. Epithelium-deficient corneal allografts display immune privilege beneath the kidney capsule
26. Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice
27. + activated leukocytes between the mother and conceptus
28. Tumor counterattack-concept and reality
29. Inhibition of death receptor signals by cellular FLIP
30. T-cell mediated responses in a murine model of orthotopic corneal transplantation
31. Human retinal pigment epithelial cell-induced apoptosis in activated T cells
32. Retinal necrosis and immune response following anterior chamber inoculation of herpes simplex virus type-1 are regulated by light
33. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction
34. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation
35. Murine xenogeneic immune responses to the human testis: A presumed immune-privileged tissue
36. Bcl-2 and Bax function independently to regulate cell death
37. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice
38. The role of T cell apoptosis in transplantation tolerance
39. Prolonged survival of rat liver allografts transfected with Fas ligand-expressing plasmid
40. Fas ligand-mediated killing by intestinal intraepithelial lymphocytes. Participation in intestinal graft-versus-host disease
41. Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity
42. Caspase 1-independent IL-1Bβ release and inflammation induced by the apoptosis inducer Fas ligand
43. The Fas death factor
44. The immune privilege of corneal allografts
45. Evidence that DNA damage triggers interleukin 10 cytokine production in UV-irradiated murine keratinocytes
46. Efficient Fas-ligand gene expression in rodent liver after intravenous injection of a recombinant adenovirus by the use of a Cre-mediated switching system
47. Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes
48. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system
49. Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis
50. Selective upregulation of fibroblast Fas ligand expression, and prolongation of Fas/Fas ligand-mediated skin allograft survival, by retinoic acid: The skin as a retinoid-inducible immune privilege site
51. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response
52. Fas ligand over expression on allograft endothelium inhibits inflammatory cell infiltration and transplant-associated intimal hyperplasia
53. Fas ligand gene transfer combined with low dose cyclosporine A reduces acute lung allograft rejection
54. Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity
55. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival
56. Expression of the Fas ligand in cell of T cell lineage
57. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis
58. Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses
59. Transgenic expression of CD95 ligand on thyroid follicular cells confers immune privilege upon thyroid allografts
60. Fas ligand-transfected myoblasts and islet cell transplantation
61. Fas ligand-deficient gld mice are more susceptible to graft-versus-host-disease
62. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants
63. Antigen presenting cells expressing Fas ligand down modulate chronic inflammatory disease in Fas ligand deficient mice
64. Characterization of a novel cis-element that regulates Fas ligand expression in corneal endothelial cells